Royalty Pharma plc announced on January 9, 2025, that its board of directors has declared a dividend for the first quarter of 2025 of $0.22 per Class A ordinary share. This represents a 5% increase in the company’s quarterly dividend compared to the previous quarter.
The increased dividend will be paid on March 10, 2025, to shareholders of record at the close of business on February 21, 2025. This action reflects Royalty Pharma's commitment to returning capital to shareholders and its confidence in its financial outlook.
The consistent growth in dividends is a key component of Royalty Pharma's capital allocation strategy, complementing its investments in new royalties and share repurchases to drive long-term shareholder value.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.